TICAM1 and infection: IEIs of TLR3-, IRF7-, UNC93B1-, TICAM1-, TBK1-, and interferon alpha and beta receptor subunit 1 (IFNAR1)-dependent type I interferon immunity have been described to underlie life-threatening COVID-19 pneumonia in patients with no prior severe infection [10, 133].